Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
97.02
-0.77 (-0.79%)
Mar 13, 2026, 4:00 PM EDT - Market closed
Glaukos Employees
Glaukos had 1,094 employees as of December 31, 2025. The number of employees increased by 99 or 9.95% compared to the previous year.
Employees
1,094
Change (1Y)
99
Growth (1Y)
9.95%
Revenue / Employee
$463,841
Profits / Employee
-$171,564
Market Cap
5.63B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,094 | 99 | 9.95% |
| Dec 31, 2024 | 995 | 88 | 9.70% |
| Dec 31, 2023 | 907 | 124 | 15.84% |
| Dec 31, 2022 | 783 | 56 | 7.70% |
| Dec 31, 2021 | 727 | 74 | 11.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bruker | 11,085 |
| Integer Holdings | 11,000 |
| Bio-Rad Laboratories | 7,450 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Penumbra | 4,700 |
| LivaNova | 3,300 |
| Haemonetics | 3,023 |
GKOS News
- 25 days ago - These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Benzinga
- 26 days ago - Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 5 weeks ago - Alger Weatherbie Specialized Growth Fund Q4 2025 Winners And Laggards - Seeking Alpha
- 6 weeks ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 6 weeks ago - Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR - Business Wire
- 7 weeks ago - Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 - Business Wire
- 2 months ago - Glaukos Corporation (GKOS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha